Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4244211
Max Phase: Preclinical
Molecular Formula: C53H99N17O12
Molecular Weight: 1166.48
Molecule Type: Small molecule
Associated Items:
ID: ALA4244211
Max Phase: Preclinical
Molecular Formula: C53H99N17O12
Molecular Weight: 1166.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(N)=O)C(C)C
Standard InChI: InChI=1S/C53H99N17O12/c1-27(2)22-37(62-32(11)71)47(78)67-39(24-29(5)6)49(80)69-40(25-30(7)8)50(81)68-38(23-28(3)4)48(79)64-35(18-15-21-61-53(58)59)46(77)70-42(31(9)10)51(82)65-33(16-12-13-19-54)44(75)63-34(17-14-20-60-52(56)57)45(76)66-36(43(55)74)26-41(72)73/h27-31,33-40,42H,12-26,54H2,1-11H3,(H2,55,74)(H,62,71)(H,63,75)(H,64,79)(H,65,82)(H,66,76)(H,67,78)(H,68,81)(H,69,80)(H,70,77)(H,72,73)(H4,56,57,60)(H4,58,59,61)/t33-,34-,35-,36-,37-,38-,39-,40-,42-/m0/s1
Standard InChI Key: QFGRBFXJHAZDPE-FYEYUANWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1166.48 | Molecular Weight (Monoisotopic): 1165.7659 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Dianati V, Kwiatkowska A, Couture F, Desjardins R, Dory YL, Day R.. (2018) Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines., 61 (18): [PMID:30180568] [10.1021/acs.jmedchem.8b01144] |
Source(1):